Clinical Trials · NCT03017352
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Filip Krag Knop
- Enrollment
- 108
- Start date
- Dec 2016
- Locations
- 1 site, Denmark
- Primary endpoint
- Change in HbA1c